Brca1-deficient murine mammary epithelial cells have increased sensitivity to CDDP and MMS

被引:47
|
作者
Sgagias, MK
Wagner, KU
Hamik, B
Stoeger, S
Spieker, R
Huber, LJ
Chodosh, LA
Cowan, KH
机构
[1] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA
[2] Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA
关键词
Bcra1-deficiency; DNA-damage and repair; breast cancer; CDDP; MMS;
D O I
10.4161/cc.3.11.1211
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In this report we describe the isolation of an isogenic pair of Brca1(++) and Brca1(-/-) murine mammary epithelial cells (MMECs). These cells were isolated from Brca1 conditional knock-out mice which contained loxP sites flanking exon 11 of the Brca1 gene (Brca1(f1/f1)) and then immortalized by infection with HPV-16E6 retrovirus to degrade p53 protein. Brca1-/- MMECs were generated by deletion of exon 11 following transduction of Brca1(f1/f1) MMECs with a retroviral vector expressing Cre recombinase. Brca1-deficiency rendered MMECs sensitive to cis-platinum (II) diamine dichloride ( CDDP) and methylmethane sulfonate (MMS). The Brca1(+/+) and Brca1(-/-) MMECs is the only known pair of isogenic mammary epithelial cell lines. The understanding of the mechanisms of the CDDP sensitivity of the BRCA1-deficient mammary epithelial cells would be very important in understanding how BRCA1-deficiency plays a role in tissue specific breast cancer chemotherapy. These studies support the role of BRCA1 in the CDDP-induced and MMS-induced DNA damage and repair by p53-independent pathways.
引用
收藏
页码:1451 / 1456
页数:6
相关论文
共 50 条
  • [21] EXO1 protects BRCA1-deficient cells against toxic DNA lesions
    van de Kooij, Bert
    Schreuder, Anne
    Pavani, Raphael
    Garzero, Veronica
    Uruci, Sidrit
    Wendel, Tiemen J.
    Hoeck, Arne van
    Alonso, Marta San Martin
    Everts, Marieke
    Koerse, Dana
    Callen, Elsa
    Boom, Jasper
    Mei, Hailiang
    Cuppen, Edwin
    Luijsterburg, Martijn S.
    van Vugt, Marcel A. T. M.
    Nussenzweig, Andre
    van Attikum, Haico
    Noordermeer, Sylvie M.
    MOLECULAR CELL, 2024, 84 (04) : 659 - 674.e7
  • [22] Replicated chromatin curtails 53BP1 recruitment in BRCA1-proficient and BRCA1-deficient cells
    Michelena, Jone
    Pellegrino, Stefania
    Spegg, Vincent
    Altmeyer, Matthias
    LIFE SCIENCE ALLIANCE, 2021, 4 (06)
  • [23] Global analysis of differentially expressed genes in BRCA1-deficient murine ovarian cancer cell lines
    Lang, Jennifer
    Xing, Deyin
    Orsulic, Sandra
    CANCER RESEARCH, 2009, 69
  • [24] BRCA1 deficient cells have increased fragile site expression that is complemented by wild type BRCA1.
    Arlt, MF
    Durkin, SG
    Casper, AM
    Kastan, MB
    Glover, TW
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 181 - 181
  • [25] Chromosome aberrations, aneuploidy, and abnormal cell division in Brca1-deficient mice and in the mammary tumors of Brca1 conditional mutants.
    Weaver, ZA
    Xu, X
    Larson, D
    Wynshaw-Boris, A
    Deng, CX
    Ried, T
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A37 - A37
  • [26] Inhibition of alternative NF-κB activity prevents the expansion of genetically unstable progenitor cells in BRCA1-deficient mammary glands
    Sau, Andrea
    Lau, Rosanna
    Nolan, Emma
    Crooks, Peter A.
    Visvader, Jane E.
    Pratt, Christine M. A.
    CANCER RESEARCH, 2015, 75
  • [27] Progesterone Receptor A Stability Is Mediated by Glycogen Synthase Kinase-3β in the Brca1-deficient Mammary Gland
    Wang, Shaohui
    Li, Ying
    Hsu, Pang-Hung
    Lee, Sou-Ying
    Kim, Yoon
    Lee, Eva Y. -H. P.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (36) : 26265 - 26274
  • [28] Lack of ABCG2 Shortens Latency of BRCA1-Deficient Mammary Tumors and This Is Not Affected by Genistein or Resveratrol
    Zander, Serge A. L.
    Kersbergen, Ariena
    Sol, Wendy
    Gonggrijp, Maaike
    van de Wetering, Koen
    Jonkers, Jos
    Borst, Piet
    Rottenberg, Sven
    CANCER PREVENTION RESEARCH, 2012, 5 (08) : 1053 - 1060
  • [29] POL? processes ssDNA gaps and promotes replication fork progression in BRCA1-deficient cells
    Schrempf, Anna
    Bernardo, Sara
    Verge, Emili A. Arasa
    Otero, Miguel A. Ramirez
    Wilson, Jordan
    Kirchhofer, Dominik
    Timelthaler, Gerald
    Ambros, Anna M.
    Kaya, Atilla
    Wieder, Marcus
    Ecker, Gerhard F.
    Winter, Georg E.
    Costanzo, Vincenzo
    Loizou, Joanna I.
    CELL REPORTS, 2022, 41 (09):
  • [30] The PARP Inhibitors, Veliparib and Olaparib, Are Effective Chemopreventive Agents for Delaying Mammary Tumor Development in BRCA1-deficient Mice
    To, Ciric
    Kim, Eun-Hee
    Royce, Darlene B.
    Williams, Charlotte R.
    Collins, Ryan M.
    Risingsong, Renee
    Sporn, Michael B.
    Liby, Karen T.
    CANCER PREVENTION RESEARCH, 2014, 7 (07) : 698 - 707